定量生物发光断层成像引导适形放疗的临床前研究
本研究开发了高对比度定量生物发光断层成像(QBLT)系统,用于引导临床前胶质母细胞瘤(GBM)模型的适形放疗。QBLT可重建体内GBM,定位精度在1 mm内,添加0.5 mm边缘形成PTVQBLT后,肿瘤覆盖率从75.0%提升至平均97.9%。在处方剂量5 Gy覆盖95% PTVQBLT的目标下,QBLT引导的7野适形放疗可有效照射99.4±1.0%的GTV。
要点
- QBLT可高对比度重建体内GBM,定位精度在1 mm内。
- 0.5 mm边缘使肿瘤覆盖率从75.0%提升至平均97.9%。
- 5 Gy覆盖95% PTVQBLT时,GTV照射覆盖达99.4±1.0%。
核心结论
- QBLT可利用生物学信息进行靶区勾画并引导适形放疗,减少正常组织受累,有望提高科学发现的可重复性。
研究设计与样本
- 临床前研究,使用表达生物发光信号的胶质母细胞瘤(GBM)模型在体内验证QBLT引导的适形放疗。
主要发现
- QBLT重建体内GBM的定位精度在1 mm内。
- 添加0.5 mm边缘形成PTVQBLT后,肿瘤覆盖率从75.0%(0 mm边缘)提升至平均97.9%。
- 在处方剂量5 Gy覆盖95% PTVQBLT的目标下,QBLT引导的7野适形放疗可有效照射99.4±1.0%的GTV。
关键数值与推荐
- 确定阈值勾画QBLT重建的大体靶区(GTVQBLT),以CBCT对比剂标记的GBM(GTV)为金标准。
- 确定0.5 mm边缘加入GTVQBLT形成QBLT计划靶区(PTVQBLT)以考虑定位和勾画不确定性。
- 处方剂量5 Gy覆盖95% PTVQBLT。
临床怎么用
- 在临床前放疗研究中,可使用QBLT基于细胞活力相关的三维生物发光信号引导适形照射,提高靶区覆盖并减少正常组织照射。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Widely used cone beam computed tomography (CBCT)-guided irradiators in preclinical radiation research are limited to localize soft tissue target because of low imaging contrast. Knowledge of target volume is a fundamental need for radiation therapy (RT). Without such information to guide radiation, normal tissue can be overirradiated, introducing experimental uncertainties. This led us to develop high-contrast quantitative bioluminescence tomography (QBLT) for guidance. The use of a 3-dimensional bioluminescence signal, related to cell viability, for preclinical radiation research is one step toward biology-guided RT. METHODS AND MATERIALS: Our QBLT system enables multiprojection and multispectral bioluminescence imaging to maximize input data for the tomographic reconstruction. Accurate quantification of spectrum and dynamic change of in vivo signal were also accounted for the QBLT. A spectral-derivative method was implemented to eliminate the modeling of the light propagation from animal surface to detector. We demonstrated the QBLT capability of guiding conformal RT using a bioluminescent glioblastoma (GBM) model in vivo. A threshold was determined to delineate QBLT reconstructed gross target volume (GTVQBLT), which provides the best overlap between the GTVQBLT and CBCT contrast labeled GBM (GTV), used as the ground truth for GBM volume. To account for the uncertainty of GTVQBLT in target positioning and volume delineation, a margin was determined and added to the GTVQBLT to form a QBLT planning target volume (PTVQBLT) for guidance. RESULTS: The QBLT can reconstruct in vivo GBM with localization accuracy within 1 mm. A 0.5-mm margin was determined and added to GTVQBLT to form PTVQBLT, largely improving tumor coverage from 75.0% (0 mm margin) to 97.9% in average, while minimizing normal tissue toxicity. With the goal of prescribed dose 5 Gy covering 95% of PTVQBLT, QBLT-guided 7-field conformal RT can effectively irradiate 99.4 ± 1.0% of GTV. CONCLUSIONS: The QBLT provides a unique opportunity for investigators to use biologic information for target delineation, guiding conformal irradiation, and reducing normal tissue involvement, which is expected to increase reproducibility of scientific discovery.
引用
- Xu X, Deng Z, Dehghani H, et al. Quantitative Bioluminescence Tomography-Guided Conformal Irradiation for Preclinical Radiation Research. Int J Radiat Oncol Biol Phys. 2021. PMID: 34411639. doi:10.1016/j.ijrobp.2021.08.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。